| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1010554913 |
| P356 | DOI | 10.1007/S00296-009-0966-8 |
| P698 | PubMed publication ID | 19466418 |
| P2093 | author name string | Yi Zheng | |
| Mingwei Li | |||
| Mulan Jin | |||
| Xuhua Shi | |||
| Yongfeng Zhang | |||
| Luling Li | |||
| P2860 | cites work | Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays | Q25939005 |
| Clinical classification of pulmonary hypertension. | Q30341846 | ||
| The use of mycophenolate mofetil in transplant recipients | Q33957200 | ||
| Review of the antiproliferative properties of mycophenolate mofetil in non-immune cells | Q35619756 | ||
| Cellular and molecular mechanisms of pulmonary vascular remodeling: role in the development of pulmonary hypertension | Q35863843 | ||
| Connective tissue associated pulmonary arterial hypertension | Q36458139 | ||
| Pulmonary arterial hypertension: current therapeutic strategies | Q36830717 | ||
| Effect of cyclosporine, mycophenolic acid, and rapamycin on the proliferation of rat aortic vascular smooth muscle cells: in vitro study | Q38525562 | ||
| In vitro prevention of cyclosporin-induced cell contraction by mycophenolic acid | Q40405057 | ||
| Effects of mycophenolic acid on endothelial cells | Q40435492 | ||
| Mycophenolate mofetil (MMF, RS-61443) inhibits inflammation and smooth muscle cell proliferation in rat aortic allografts | Q42555924 | ||
| Mycophenolate mofetil prevents transplant arteriosclerosis by direct inhibition of vascular smooth muscle cell proliferation | Q44940055 | ||
| Antiproliferative profile of sirolimus and mycophenolate mofetil: impact of the SI/MPL ratio | Q46590530 | ||
| Successful rescue therapy with mycophenolate mofetil in kidney transplantation improves the long-term graft survival. | Q46817076 | ||
| Mycophenolate mofetil as the primary treatment of membranous lupus nephritis with and without concurrent proliferative disease: a retrospective study of 29 cases | Q46843590 | ||
| Mycophenolate mofetil attenuates pulmonary arterial hypertension in rats. | Q53600909 | ||
| Characterization of right ventricular function after monocrotaline-induced pulmonary hypertension in the intact rat | Q57298870 | ||
| Pulmonary Arterial Hypertension | Q58485998 | ||
| Temporal alterations in specific basement membrane components in lungs from monocrotaline-treated rats | Q70478464 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 341-348 | |
| P577 | publication date | 2009-05-23 | |
| P1433 | published in | Rheumatology International | Q15763689 |
| P1476 | title | The effects and mechanisms of mycophenolate mofetil on pulmonary arterial hypertension in rats. | |
| P478 | volume | 30 |
| Q47275610 | Effect of asiaticoside on endothelial cells in hypoxia‑induced pulmonary hypertension |
| Q55254142 | Mycophenolate Mofetil in a Lupus Patient with Pulmonary Hypertension. |
| Q33434238 | Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial |
| Q38612061 | Novel investigational therapies for treating pulmonary arterial hypertension |
| Q37705261 | Steps forward in the treatment of pulmonary arterial hypertension: latest developments and clinical opportunities |
| Q52944648 | The effects of mycophenolate mofetil on cytokines and their receptors in pulmonary arterial hypertension in rats. |
| Q38936954 | Treatment of Systemic Sclerosis-related Interstitial Lung Disease: A Review of Existing and Emerging Therapies |
| Q38846020 | Update on pulmonary arterial hypertension pharmacotherapy |
| Q40487999 | Use of Mycophenolate Mofetil or Azathioprine for the Management of Chronic Hypersensitivity Pneumonitis. |
Search more.